Atlas Trials

Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian Cancer

Clinical trial NCT05684731 · RECRUITING

Trial details

NCT number
NCT05684731
Sponsor
Tongji Hospital
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2023-02-01
Primary completion
2025-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.